Epidarex Exeed first spin-out company, Lario Therapeutics, receives “Company Making a Difference Award” from CDLK5 Forum, recognising its unique approach to precision medicine for genetic epilepsies
In All“CDLK5 Forum Award for Excellence – Company Making a Difference 2023 Pre-clinical” presented by the Loulou Foundation at the CDKL5 Forum, 6th-7th November in London First-in-class ion channel inhibitors show promise as anti-seizure therapeutics for multiple treatment-resistant epilepsy subtypes CaV2.3 identified as a novel target…